Abstract
Several investigations have unveiled multiple effects of the ployphenol curcumin on immune responses, both in physiological and in pathological conditions. Here we review the biochemistry of this compound in the context of its potential and limitations as possible therapeutic modulator of immune responses.
Keywords: Curcumin, immune response, inflammation, autoimmunity, autoimmune diseases, tumors, infection, allergy
Current Bioactive Compounds
Title: Curcumin and Immunity
Volume: 6 Issue: 3
Author(s): Antonio La Cava and Milan Fiala
Affiliation:
Keywords: Curcumin, immune response, inflammation, autoimmunity, autoimmune diseases, tumors, infection, allergy
Abstract: Several investigations have unveiled multiple effects of the ployphenol curcumin on immune responses, both in physiological and in pathological conditions. Here we review the biochemistry of this compound in the context of its potential and limitations as possible therapeutic modulator of immune responses.
Export Options
About this article
Cite this article as:
La Cava Antonio and Fiala Milan, Curcumin and Immunity, Current Bioactive Compounds 2010; 6 (3) . https://dx.doi.org/10.2174/157340710793237335
DOI https://dx.doi.org/10.2174/157340710793237335 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecules of Infectious Agents as Immunomodulatory Drugs
Current Topics in Medicinal Chemistry The Role of Carrier Geometry in Overcoming Biological Barriers to Drug Delivery
Current Pharmaceutical Design Colloidal Drug Delivery Systems in Vaccine Delivery
Current Drug Targets Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Current Pharmaceutical Design Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics Emerging Role of Stromal Fibroblasts in Epithelial Cancer
Current Signal Transduction Therapy Current Trends in Pseudogene Detection and Characterization
Current Bioinformatics Bioactive Compounds of <i>Polygonatum sibiricum</i> - Therapeutic Effect and Biological Activity
Endocrine, Metabolic & Immune Disorders - Drug Targets Combining Gene Therapy and Radiation Against Cancer
Current Gene Therapy Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy
Current Pharmaceutical Design Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Current Pharmaceutical Design Synthetic Methods of Disulfide Bonds Applied in Drug Delivery Systems
Current Organic Chemistry Valproic Acid As Anti-Cancer Drug
Current Pharmaceutical Design Vitamin D and Physical Performance in Athletes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Chemical and Biological Aspects of the Natural 1,4-Benzoquinone Embelin and its (semi-)Synthetic Derivatives
Current Medicinal Chemistry Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Receptor-Specific Peptides for Targeting of Liposomal, Polymeric, and Dendrimeric Nanoparticles in Cancer Diagnosis and Therapy
Current Molecular Imaging (Discontinued)